Emtricitabine
Generic name: Emtricitabine
Brand names: Emtriva
Drug class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Usage of Emtricitabine
Emtricitabine is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body.
Emtricitabine is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Emtricitabine is not a cure for HIV or AIDS.
Emtricitabine may also be used for purposes not listed in this medication guide.
Emtricitabine side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Early symptoms of lactic acidosis may get worse over time and this condition can be fatal. Get emergency medical help if you have even mild symptoms: muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired.
Call your doctor at once if you have symptoms of liver problems: swelling around your midsection, upper stomach pain, nausea, loss of appetite, dark urine, or jaundice (yellowing of the skin or eyes).
Emtricitabine may increase your risk of certain infections or autoimmune disorders by changing the way your immune system works. Symptoms may occur weeks or months after you start treatment with emtricitabine. Tell your doctor if you have:
Common side effects of emtricitabine may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Emtricitabine
You should not take emtricitabine if you are allergic to emtricitabine.
Do not take Emtriva if you also use other medicines that contain emtricitabine or lamivudine (such as Atripla, Combivir, Complera, Descovy, Dutrebis, Epivir, Epzicom, Genvoya, Odefsey, Stribild, Triumeq, or Trizivir).
To make sure emtricitabine is safe for you, tell your doctor if you have ever had:
Some people taking this medicine develop a serious condition called lactic acidosis. This may be more likely in women, in people who are overweight or have liver disease, and in people who have taken HIV/AIDS medication for a long time. Talk with your doctor about your risk.
HIV can be passed to your baby if you are not properly treated during pregnancy. Take all of your HIV medicines as directed to control your infection.
If you are pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of emtricitabine on the baby.
Women with HIV or AIDS should not breast-feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.
Emtricitabine is not approved for use by anyone younger than 3 months old.
Relate drugs
- Adefovir
- Abacavir
- Baraclude
- Didanosine
- Emtricitabine
- Emtriva
- Entecavir
- Epivir
- Epivir A/F
- Epivir HBV
- Hepsera
- Lamivudine
- Retrovir (Zidovudine Intravenous)
- Retrovir (Zidovudine Oral)
- Retrovir oral/injection
- Stavudine
- Telbivudine
- Tenofovir
- Tenofovir alafenamide
- Tyzeka
- Vemlidy
- Videx
- Videx EC
- Videx Pediatric
- Viread
- Zerit
- Ziagen
- Zidovudine (Intravenous)
- Zidovudine (Oral)
- Zidovudine oral/injection
How to use Emtricitabine
Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.
Emtricitabine can be taken with or without food.
Measure liquid medicine with the dosing syringe provided, or with a special dose-measuring spoon or medicine cup. If you do not have a dose-measuring device, ask your pharmacist for one.
If a child is using this medicine, tell your doctor if the child has any changes in weight. Emtricitabine doses are based on weight in children, and any changes may affect your child's dose.
Do not take emtricitabine as your only HIV medication. HIV/AIDS is usually treated with a combination of drugs. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice. Every person with HIV or AIDS should remain under the care of a doctor.
While using emtricitabine, you may need frequent blood tests. Your kidney and liver function may also need to be checked.
Get your prescription refilled before you run out of medicine completely. Your disease may become resistant to emtricitabine if you stop taking the medication even for a short time.
Store capsules at room temperature away from moisture, heat, and direct light.
Store liquid in the refrigerator. Do not freeze.
Emtricitabine liquid kept at room temperature must be used within 3 months.
If you have hepatitis B you may develop liver symptoms after you stop taking this medication, even months after stopping. Your doctor may want to check your liver function for several months after you stop using emtricitabine.
Warnings
Do not take Emtriva if you also take other medicines that contain emtricitabine or lamivudine.
Emtricitabine may cause a serious condition called lactic acidosis. Get emergency medical help if you have even mild symptoms such as: muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired.
If you have hepatitis B you may develop liver symptoms after you stop taking emtricitabine, even months after stopping.
What other drugs will affect Emtricitabine
Other drugs may interact with emtricitabine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions